Literature DB >> 24597516

The stem of vesicular stomatitis virus G can be replaced with the HIV-1 Env membrane-proximal external region without loss of G function or membrane-proximal external region antigenic properties.

Ivo C Lorenz1, Hanh T Nguyen, Marina Kemelman, Ross W Lindsay, Maoli Yuan, Kevin J Wright, Heather Arendt, Jaap Willem Back, Joanne DeStefano, Simon Hoffenberg, Gavin Morrow, Christy K Jurgens, Sanjay K Phogat, Timothy J Zamb, Christopher L Parks.   

Abstract

The structure of the HIV-1 envelope membrane-proximal external region (MPER) is influenced by its association with the lipid bilayer on the surface of virus particles and infected cells. To develop a replicating vaccine vector displaying MPER sequences in association with membrane, Env epitopes recognized by the broadly neutralizing antibodies 2F5, 4E10, or both were grafted into the membrane-proximal stem region of the vesicular stomatitis virus (VSV) glycoprotein (G). VSV encoding functional G-MPER chimeras based on G from the Indiana or New Jersey serotype propagated efficiently, although grafting of both epitopes (G-2F5-4E10) modestly reduced replication and resulted in the acquisition of one to two adaptive mutations in the grafted MPER sequence. Monoclonal antibodies 2F5 and 4E10 efficiently neutralized VSV G-MPER vectors and bound to virus particles in solution, indicating that the epitopes were accessible in the preattachment form of the G-MPER chimeras. Overall, our results showed that the HIV Env MPER could functionally substitute for the VSV G-stem region implying that both perform similar functions even though they are from unrelated viruses. Furthermore, we found that the MPER sequence grafts induced low but detectable MPER-specific antibody responses in rabbits vaccinated with live VSV, although additional vector and immunogen modifications or use of a heterologous prime-boost vaccination regimen will be required to increase the magnitude of the immune response.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24597516      PMCID: PMC4208592          DOI: 10.1089/AID.2013.0206

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  76 in total

1.  Comparative analysis of amino acid distributions in integral membrane proteins from 107 genomes.

Authors:  Johan Nilsson; Bengt Persson; Gunnar von Heijne
Journal:  Proteins       Date:  2005-09-01

2.  An efficient helper-virus-free method for rescue of recombinant paramyxoviruses and rhadoviruses from a cell line suitable for vaccine development.

Authors:  Susan E Witko; Cheryl S Kotash; Rebecca M Nowak; J Erik Johnson; Lee Anne C Boutilier; Krista J Melville; Sannyu G Heron; David K Clarke; Aaron S Abramovitz; R Michael Hendry; Mohinder S Sidhu; Stephen A Udem; Christopher L Parks
Journal:  J Virol Methods       Date:  2006-03-29       Impact factor: 2.014

Review 3.  The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design.

Authors:  Marinieve Montero; Nienke E van Houten; Xin Wang; Jamie K Scott
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 11.056

4.  Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.

Authors:  Min Luo; Fei Yuan; Yanxia Liu; Siming Jiang; Xijun Song; Pengfei Jiang; Xiaolei Yin; Mingxiao Ding; Hongkui Deng
Journal:  Vaccine       Date:  2005-08-18       Impact factor: 3.641

Review 5.  Rational modifications of HIV-1 envelope glycoproteins for immunogen design.

Authors:  S Phogat; R Wyatt
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

6.  Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.

Authors:  S Phogat; K Svehla; M Tang; A Spadaccini; J Muller; J Mascola; I Berkower; R Wyatt
Journal:  Virology       Date:  2007-12-26       Impact factor: 3.616

7.  Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays.

Authors:  David C Montefiori
Journal:  Curr Protoc Immunol       Date:  2005-01

8.  Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates.

Authors:  Véronique Zennou; Paul D Bieniasz
Journal:  Virology       Date:  2006-02-07       Impact factor: 3.616

9.  HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane.

Authors:  Zhen-Yu J Sun; Kyoung Joon Oh; Mikyung Kim; Jessica Yu; Vladimir Brusic; Likai Song; Zhisong Qiao; Jia-huai Wang; Gerhard Wagner; Ellis L Reinherz
Journal:  Immunity       Date:  2008-01       Impact factor: 31.745

Review 10.  Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector.

Authors:  David K Clarke; David Cooper; Michael A Egan; R Michael Hendry; Christopher L Parks; Stephen A Udem
Journal:  Springer Semin Immunopathol       Date:  2006-09-15
View more
  2 in total

Review 1.  The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects.

Authors:  Huan Liu; Xiaojie Su; Lulu Si; Lu Lu; Shibo Jiang
Journal:  Protein Cell       Date:  2018-04-17       Impact factor: 14.870

Review 2.  Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses.

Authors:  Trina Racine; Gary P Kobinger; Eric J Arts
Journal:  AIDS Res Ther       Date:  2017-09-12       Impact factor: 2.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.